Diabetic Retinopathy Clinical Research Network (DRCRnet) public web site

DRCR.net Overview

DRCR.net Overview


 

Aflibercept, Bevacizumab, or Ranibizumab for DME: Two-year Results

Click here to view presentation of 2 year results


Click here for manuscript


Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial

Click here to view presentation of primary outcome results

(Please notify the DRCR.net Coordinating Center (drcrnet@jaeb.org) if slide set is used for a non-local meeting presentation.)


Click here for manuscript

 

 


Primary Outcome Presentations
 
1.     Protocol I - Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema Click here for presentation

2.     Protocol I - Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt vs Deferred Laser Treatment: 3-year Randomized Trial Results Click here for presentation

3.     Protocol I - 5-Year Follow-up of a Randomized Trial Evaluating Ranibizumab Plus Prompt versus Deferred Laser for Diabetic Macular Edema Click here for presentation

4.     Protocol M - Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control Click here for presentation 

5.     Protocol N - Randomized Clinical Trial Evaluating Intravitreal Ranibizumab or Intravitreal Saline for Vitreous Hemorrhage from Proliferative Diabetic Retinopathy Click here for presentation  

6.    Protocol T - A Comparative Effectiveness  Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema Click here for presentation

 

Secondary Outcome Presentations
 
1.      Protocol I - Rationale for the DRCR.net Treatment Protocol for Center-Involved DME Click here for presentation
 
2.      Protocol I - Green or Yellow Laser Treatment for Diabetic Macular Edema Click here for presentation
 
3.      Protocol I - Expanded 2-year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema Click here for presentation
 
4.      Protocol I - Worsening of Diabetic Retinopathy in a Randomized Clinical Trial Evaluating Ranibizumab and Triamcinolone: Exploratory Analysis Click here for presentation
 
5.      Protocol I - Repeated Intravitreous Ranibizumab Injections for DME and Risk of Sustained IOP Elevation or Need for Ocular Hypotensive Treatment Click here for presentation
 
6.      Protocol I - Factors Associated with Changes in Visual Acuity and OCT Thickness at 1 Year after Treatment or Diabetic Macular Edema Click here for presentation
 
7.      Protocol I - An Evaluation of Study Participant Masking of Intraocular Injections in a Randomized Clinical Trial Click here for presentation
 
8.     Protocol I - Persistent Macular Thickening After Ranibizumab Treatment or Diabetic Macular Edema with Vision Impairment: An Exploratory Analysis  Click here for presentation
 
9.     General - The Importance of Using Povidone-Iodine and Elimination of Topical Antibiotics for Intravitreous Injections: Update from the DRCR.net Click here for presentation
 
10.    Ranibizumab Plus Prompt or Deferred Laser for Diabetic Macular Edema in Eyes with Vitrectomy Prior to Anti-Vascular Endothelial Growth Factor Therapy Click here for presentation

 11.     Cost-Effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema  sTreatment: Analysis from the Diabetic Retinopathy Clinical Research Network Comparative  sEffectiveness Trial  Click here for presentation  

 

 

 
 

  


© 2007 -2017 Jaeb Center for Health Research
All forms and reports on this site require Adobe Acrobat Reader. Click HERE to download a free copy of Adobe.
Although JCHR supports various web browsers, only Internet Explorer version 11 is fully tested and validated to function on this site.
This site utilizes popup windows.